Crossing a transgenic MLL-AF4 mouse line with a transgenic Kras mouse line [57] resulted in the mice developing B cell lymphoma or leukaemia characterised by the accumulation of B220+CD43+CD19+ blasts, splenomegaly and infiltration of malignant cells in the lungs. This evidence concerns the gene CD19 and leukemia.